News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

Lapse and Forfeit of Unlisted Conditional Performance Rights

2017 Announcements

11.04.2017

CLINUVEL reaches agreement on German SCENESSE® pricing through AMNOG Arbitration Board

2017 Announcements

11.04.2017

Appendix 4D and Half Year Report

2017 Announcements

24.02.2017

CLINUVEL Newsletter – February 2017

2017 Announcements

15.02.2017

Appendix 4C – Quarterly report

2016 Announcements

31.01.2017

Appendix 3Y

2016 Announcements

22.12.2016

CLINUVEL Newsletter – December 2016

2016 Announcements

20.12.2016

Appendix 3Y

2016 Announcements

12.12.2016

Results of Meeting

2016 Announcements

28.11.2016

Chair’s Address to the Annual General Meeting

2016 Announcements

27.11.2016

Managing Director’s AGM Presentation

2016 Announcements

27.11.2016

CLINUVEL agrees with FDA on New Drug Application timelines

2016 Announcements

08.11.2016

Response to Price Query

2016 Announcements

31.10.2016

.

Go To Top